Investor FAQs
IBEX Headquarters:
1717 Pennsylvania Avenue NW, Suite 825
Washington, DC 20006
IBEX first issued shares to the public on August 7, 2020. The ticker symbol is "IBEX".
IBEX is publicly traded on the Nasdaq Global Market.
IBEX’s CUSIP number is G4690M101
The transfer agent and registrar for IBEX Limited common stock:
Broadridge
shareholder@broadridge.com
1-877-830-4936 OR 855-627-5080
IBEX does not have a direct stock purchase plan.
IBEX does not currently pay dividends.
IBEX fiscal year ends on June 30.
Daniel Burris, daniel.burris@ibex.co
Michael Darwal, michael.darwal@ibex.co
Please go to the E-mail Alerts section of the investor relations website: https://investors.ibex.co/investor-resources/email-alerts
Please go to the Investor Calendar section of the investor relations website: https://investors.ibex.co/news-events/investor-calendar